A digital bridge: could an online pathway ease depression in cancer care?

NCT ID NCT05302375

Ongoing Symptom relief Sponsor: Dartmouth-Hitchcock Medical Center Source: ClinicalTrials.gov ↗

First seen Aug 07, 2026 · Last updated Aug 07, 2026

Summary

This study tests an online pathway called iPath*D that guides cancer patients who report depression symptoms from screening to treatment options. The goal is to see if the tool is acceptable and easy to use for adults starting cancer treatment. Researchers will measure usability, feasibility, and whether patients take steps to access mental health support.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: An online pathway (iPath*D) that guides cancer patients from depression screening to treatment options.
What this could lead to: If successful, this online tool could make it easier for cancer patients to recognize and get help for depression, improving their quality of life.
What could go wrong: This is a small early-stage study focused on usability and feasibility, not effectiveness. The tool may not work for everyone or may not be widely adopted.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer Depression depressive disorder neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER DEPRESSION

Contacts and locations

Locations

Dartmouth Cancer Center St. Johnsbury

Saint Johnsbury, Vermont, 05819, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.